Status:
UNKNOWN
Decreasing Depression and Anxiety and Their Effect on QoL of ESRD Patients (End-Stage Renal Disease)
Lead Sponsor:
Hospital Civil de Guadalajara
Collaborating Sponsors:
University of Guadalajara
Conditions:
End-Stage Renal Disease
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
This study evaluates the effect of a single cognitive-behavioral intervention (CBI) in a control group against the same CBI plus the strengthening of resiliency skills in an experimental group, on ESR...
Detailed Description
Cognitive behavioral therapy has long been an alternative in the treatment of symptoms of depression and anxiety in patients with chronic diseases such as renal failure, however the combination of the...
Eligibility Criteria
Inclusion
- Older than 18, and younger than 61 years old
- Depression score in the Beck Depression Inventory (BDI) greater than 30 points.
- Anxiety score in the Beck Anxiety Inventory (BAI) greater than 40 points.
- Have not been hospitalized over the last 6 months
- Signing of informed consent
Exclusion
- May not be able to communicate in the Spanish language.
- Presence of psychiatric comorbidity (suicide ideation or depressive or anxious).
Key Trial Info
Start Date :
December 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2018
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03330938
Start Date
December 1 2017
End Date
December 30 2018
Last Update
July 24 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cristina Jazmín Gonzalez Flores
Guadalajara, Jalisco, Mexico, 44280